Eli Lilly & Co. (LLY) Tops Q1 EPS by 49c, Updates Guidance

(Updated - April 28, 2022 6:30 AM EDT)

Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $2.62, $0.49 better than the analyst estimate of $2.13. Revenue for the quarter came in at $7.81 billion versus the consensus estimate of $6.68 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2022 EPS of $8.15-$8.30, versus the consensus of $8.19. The company sees revenue to be between $28.8 billion and $29.3 billion vs consensus of $26.8 billion.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.

You May Also Be Interested In

• William Blair Downgrades On Holding AG (ONON) to Market Perform
• 908 Devices Inc. (MASS) Misses Q2 EPS by 17c ; Offers Guidance
• Coya Therapeutics, Inc. (COYA) Tops Q2 EPS by 42c